UniProt ID | STING_HUMAN | |
---|---|---|
UniProt AC | Q86WV6 | |
Protein Name | Stimulator of interferon genes protein {ECO:0000303|PubMed:18724357} | |
Gene Name | TMEM173 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 379 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Mitochondrion outer membrane Multi-pass membrane protein . Cell membrane Multi-pass membrane protein . Cytoplasm, perinuclear region . Cytoplasm . In response to double-stranded DNA s |
|
Protein Description | Facilitator of innate immune signaling that acts as a sensor of cytosolic DNA from bacteria and viruses and promotes the production of type I interferon (IFN-alpha and IFN-beta). Innate immune response is triggered in response to non-CpG double-stranded DNA from viruses and bacteria delivered to the cytoplasm. Acts by recognizing and binding cyclic di-GMP (c-di-GMP), a second messenger produced by bacteria, and cyclic GMP-AMP (cGAMP), a messenger produced in response to DNA virus in the cytosol: upon binding of c-di-GMP or cGAMP, autoinhibition is alleviated and TMEM173/STING is able to activate both NF-kappa-B and IRF3 transcription pathways to induce expression of type I interferon and exert a potent anti-viral state. May be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons. May be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II). Mediates death signaling via activation of the extracellular signal-regulated kinase (ERK) pathway. Essential for the induction of IFN-beta in response to human herpes simplex virus 1 (HHV-1) infection. Exhibits 2',3' phosphodiester linkage-specific ligand recognition. Can bind both 2'-3' linked cGAMP and 3'-3' linked cGAMP but is preferentially activated by 2'-3' linked cGAMP. [PubMed: 26300263; (Microbial infection) Antiviral activity is antagonized by oncoproteins, such as papillomavirus (HPV) protein E7 and adenovirus early E1A protein] | |
Protein Sequence | MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDHAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Ubiquitination | PRGHGAQKAALVLLS CCCCHHHHHHHHHHH | PubMed | ||
84 | Phosphorylation | YRGSYWRTVRACLGC HCCCHHHHHHHHHCC | 27251275 | ||
137 | Ubiquitination | LNILLGLKGLAPAEI HHHHHCCCCCCHHHH | PubMed | ||
150 | Ubiquitination | EISAVCEKGNFNVAH HHHHHHHCCCCCHHH | 19285439 | ||
195 | Phosphorylation | NLLRGAVSQRLYILL HHHHHHHHCCEEEEE | 29507054 | ||
229 | Phosphorylation | LDKLPQQTGDHAGIK HHCCCCCCCCCCCCC | 24247654 | ||
240 | Phosphorylation | AGIKDRVYSNSIYEL CCCCCCCHHCHHHHH | 28450419 | ||
241 | Phosphorylation | GIKDRVYSNSIYELL CCCCCCHHCHHHHHH | 28450419 | ||
243 | Phosphorylation | KDRVYSNSIYELLEN CCCCHHCHHHHHHHC | 28450419 | ||
245 | Phosphorylation | RVYSNSIYELLENGQ CCHHCHHHHHHHCCC | 28450419 | ||
289 | Ubiquitination | EDRLEQAKLFCRTLE HHHHHHHHHHHHHHH | - | ||
338 | Ubiquitination | RHLRQEEKEEVTVGS HHHHHHHHCCCCCCH | - | ||
342 | Phosphorylation | QEEKEEVTVGSLKTS HHHHCCCCCCHHCCC | 29514088 | ||
345 | Phosphorylation | KEEVTVGSLKTSAVP HCCCCCCHHCCCCCC | 29514088 | ||
353 | Phosphorylation | LKTSAVPSTSTMSQE HCCCCCCCCCCCCCC | 28857561 | ||
354 | Phosphorylation | KTSAVPSTSTMSQEP CCCCCCCCCCCCCCC | 28857561 | ||
355 | Phosphorylation | TSAVPSTSTMSQEPE CCCCCCCCCCCCCCC | 28348404 | ||
356 | Phosphorylation | SAVPSTSTMSQEPEL CCCCCCCCCCCCCCE | 28348404 | ||
358 | Phosphorylation | VPSTSTMSQEPELLI CCCCCCCCCCCCEEE | 28348404 | ||
366 | Phosphorylation | QEPELLISGMEKPLP CCCCEEECCCCCCCC | 27302953 | ||
370 | Ubiquitination | LLISGMEKPLPLRTD EEECCCCCCCCCCCC | - | ||
376 | Phosphorylation | EKPLPLRTDFS---- CCCCCCCCCCC---- | 23090842 | ||
379 | Phosphorylation | LPLRTDFS------- CCCCCCCC------- | 23090842 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
358 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | Uniprot |
366 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | Uniprot |
366 | S | Phosphorylation | Kinase | ULK1 | O75385 | PSP |
366 | S | Phosphorylation | Kinase | ULK2 | Q8IYT8 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM32 | Q13049 | PMID:22745133 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF26 | Q9BY78 | PMID:25254379 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM56 | Q9BRZ2 | PMID:23189823 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF5 | Q99942 | PMID:19285439 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STING_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
615934 | STING-associated vasculopathy, infantile-onset (SAVI) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...